WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareBiotechnology
Best Biotech Stocks to Buy Now (2022)
Top biotech stocks in 2022 ranked by overall Zen Score. See the best biotech stocks to buy now, according to analyst forecasts for the biotechnology industry.

Industry: Biotechnology
Ticker
Company
Exchange
Industry
Zen Score
Market Cap
Price
1d %
EBITDA
P/E
D/E
CLGN
COLLPLANT BIOTECHNOLOGIES LTD
NASDAQ
Biotechnology
$97.06M$9.01-8.81%$838.00k450.50x0.14
CPRX
CATALYST PHARMACEUTICALS INC
NASDAQ
Biotechnology
$706.10M$6.87-0.72%$60.73M15.61x0.12
EXEL
EXELIXIS INC
NASDAQ
Biotechnology
$5.68B$17.70-0.28%$401.79M18.83x0.16
HALO
HALOZYME THERAPEUTICS INC
NASDAQ
Biotechnology
$6.18B$44.821.11%$305.20M14.55x3.47
HRMY
HARMONY BIOSCIENCES HOLDINGS INC
NASDAQ
Biotechnology
$2.45B$41.502.32%$94.18M50.00x1.16
INCY
INCYTE CORP
NASDAQ
Biotechnology
$16.64B$75.11-2.34%$634.33M17.80x0.31
SESN
SESEN BIO INC
NASDAQ
Biotechnology
$103.92M$0.521.36%$45.82M2.00x0.31
MRNA
MODERNA INC
NASDAQ
Biotechnology
$52.53B$132.06-4.04%$16.55B3.63x0.62
CLNN
CLENE INC
NASDAQ
Biotechnology
$153.71M$2.43-10.99%$18.51M8.68x25.46
CORT
CORCEPT THERAPEUTICS INC
NASDAQ
Biotechnology
$2.13B$20.00-0.25%$134.73M20.20x0.15
CDMO
AVID BIOSERVICES INC
NASDAQ
Biotechnology
$764.40M$12.382.23%$21.33M77.38x4.55
XOMA
XOMA CORP
NASDAQ
Biotechnology
$197.13M$17.26-3.41%$21.32M15.98x0.14
CRSP
CRISPR THERAPEUTICS AG
NASDAQ
Biotechnology
$4.06B$52.38-4.26%$337.79M12.65x0.16
REGN
REGENERON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$75.36B$686.020.60%$9.48B9.15x0.32
GMAB
GENMAB A
NASDAQ
Biotechnology
$20.07B$30.53-0.97%$582.54M59.63x0.10
VRTX
VERTEX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$68.67B$268.480.05%$3.06B28.08x0.31
UTHR
UNITED THERAPEUTICS CORP
NASDAQ
Biotechnology
$9.92B$218.954.19%$938.70M14.35x0.28
TECH
BIO-TECHNE CORP
NASDAQ
Biotechnology
$14.01B$357.17-2.01%$352.93M62.12x0.34
BNTX
BIONTECH SE
NASDAQ
Biotechnology
$37.55B$154.50-5.34%$19.99B1.77x0.28
AVIR
ATEA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$626.93M$7.533.15%$65.85M12.98x0.06
QURE
UNIQURE NV
NASDAQ
Biotechnology
$662.40M$14.206.29%$342.85M2.01x0.39
UPC
UNIVERSE PHARMACEUTICALS INC
NASDAQ
Biotechnology
$23.19M$1.07-2.20%$14.23M1.52x0.19
LJPC
LA JOLLA PHARMACEUTICAL CO
NASDAQ
Biotechnology
$95.84M$3.75-1.83%$17.40M18.75x-2.37
XNCR
XENCOR INC
NASDAQ
Biotechnology
$1.34B$22.45-1.32%$116.74M12.01x0.12
PRTA
PROTHENA CORP PUBLIC LTD CO
NASDAQ
Biotechnology
$1.21B$25.95-1.82%$72.78M18.15x0.33
NBIX
NEUROCRINE BIOSCIENCES INC
NASDAQ
Biotechnology
$8.09B$84.60-2.19%$129.30M111.32x0.54
GNFT
GENFIT SA
NASDAQ
Biotechnology
$171.86M$3.45-5.74%$86.24M2.10x1.37
CLSD
CLEARSIDE BIOMEDICAL INC
NASDAQ
Biotechnology
$78.20M$1.30-8.45%$262.00k130.00x0.14
SIGA
SIGA TECHNOLOGIES INC
NASDAQ
Biotechnology
$662.52M$9.15-15.51%$89.81M9.84x0.10
ACST
ACASTI PHARMA INC
NASDAQ
Biotechnology
$40.30M$0.910.22%-$8.30M-3.03x0.03
SELB
SELECTA BIOSCIENCES INC
NASDAQ
Biotechnology
$104.90M$0.69-7.74%$49.03M3.00x1.61
CARA
CARA THERAPEUTICS INC
NASDAQ
Biotechnology
$443.20M$8.27-3.27%-$91.31M-4.62x0.10
AUPH
AURINIA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.60B$11.31-4.48%-$164.54M-8.84x0.13
VNDA
VANDA PHARMACEUTICALS INC
NASDAQ
Biotechnology
$543.43M$9.62-1.23%$27.20M29.15x0.20
RGNX
REGENXBIO INC
NASDAQ
Biotechnology
$834.64M$19.35-1.07%$150.55M8.00x0.49
LQDA
LIQUIDIA CORP
NASDAQ
Biotechnology
$216.84M$3.37-28.30%-$35.04M-4.21x0.69
OPNT
OPIANT PHARMACEUTICALS INC
NASDAQ
Biotechnology
$66.64M$13.10-4.45%-$3.68M-11.80x0.54
ATNM
ACTINIUM PHARMACEUTICALS INC
NYSEMKT
Biotechnology
$132.48M$5.57-5.91%-$24.05M-4.89x0.08
LUMO
LUMOS PHARMA INC
NASDAQ
Biotechnology
$64.11M$7.66-3.04%-$30.15M-2.19x0.14
EDIT
EDITAS MEDICINE INC
NASDAQ
Biotechnology
$685.72M$9.99-8.26%-$183.52M-3.66x0.22
LPTX
LEAP THERAPEUTICS INC
NASDAQ
Biotechnology
$98.92M$1.12-1.75%-$41.87M-2.60x0.08
VTGN
VISTAGEN THERAPEUTICS INC
NASDAQ
Biotechnology
$210.66M$1.02-1.92%-$36.69M-2.22x0.13
ABCM
ABCAM PLC
NASDAQ
Biotechnology
$3.20B$13.98-6.05%$2.60M559.20x0.50
HSTO
HISTOGEN INC
NASDAQ
Biotechnology
$8.94M$0.18-2.19%-$11.24M-0.66x0.37
VIR
VIR BIOTECHNOLOGY INC
NASDAQ
Biotechnology
$3.02B$22.82-5.47%$1.65B2.45x0.44
RPTX
REPARE THERAPEUTICS INC
NASDAQ
Biotechnology
$370.35M$8.84-5.15%-$118.05M-2.87x0.30
AVEO
AVEO PHARMACEUTICALS INC
NASDAQ
Biotechnology
$137.91M$4.00-0.50%-$36.73M-3.36x1.66
GANX
GAIN THERAPEUTICS INC
NASDAQ
Biotechnology
$30.42M$2.56-8.90%-$14.69M-2.08x0.18
SEER
SEER INC
NASDAQ
Biotechnology
$444.59M$7.12-6.56%-$73.86M-5.61x0.08
STTK
SHATTUCK LABS INC
NASDAQ
Biotechnology
$119.93M$2.83-5.03%-$56.00M-2.08x0.09
FBIO
FORTRESS BIOTECH INC
NASDAQ
Biotechnology
$89.80M$0.84-6.17%-$51.22M-0.37x2.19
ZLAB
ZAI LAB LTD
NASDAQ
Biotechnology
$3.33B$34.05-8.15%-$540.09M-5.76x0.15
BMRN
BIOMARIN PHARMACEUTICAL INC
NASDAQ
Biotechnology
$14.57B$78.78-1.97%$158.35M375.14x0.38
ADAG
ADAGENE INC
NASDAQ
Biotechnology
$123.17M$2.820.00%-$69.99M-1.55x0.21
BGNE
BEIGENE LTD
NASDAQ
Biotechnology
$12.70B$122.99-9.01%-$1.87B-79.35x0.36
LOGC
LOGICBIO THERAPEUTICS INC
NASDAQ
Biotechnology
$13.71M$0.42-9.76%-$33.67M-0.37x1.08
CDXS
CODEXIS INC
NASDAQ
Biotechnology
$643.24M$9.85-6.28%-$13.32M-29.85x0.48
SLRX
SALARIUS PHARMACEUTICALS INC
NASDAQ
Biotechnology
$9.93M$0.18-6.35%-$17.01M-0.48x0.06
CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC
NASDAQ
Biotechnology
$9.51M$1.00-0.99%-$5.74M-0.28x0.04
BYSI
BEYONDSPRING INC
NASDAQ
Biotechnology
$44.77M$1.15-8.00%-$60.46M-0.70x2.07
IMMP
IMMUTEP LTD
NASDAQ
Biotechnology
$232.32M$2.720.74%-$19.07M-11.93x0.10
INMB
INMUNE BIO INC
NASDAQ
Biotechnology
$98.34M$5.48-24.62%-$32.69M-2.84x0.25
ALBO
ALBIREO PHARMA INC
NASDAQ
Biotechnology
$408.36M$20.86-3.25%-$19.53M-12.27x0.76
NVO
NOVO NORDISK A S
NYSE
Biotechnology
$249.43B$107.980.13%$9.92B35.55x1.96
SNDX
SYNDAX PHARMACEUTICALS INC
NASDAQ
Biotechnology
$796.81M$14.17-2.68%$17.87M36.33x0.13
EIGR
EIGER BIOPHARMACEUTICALS INC
NASDAQ
Biotechnology
$285.23M$6.60-2.37%-$81.38M-2.64x0.58
EYEN
EYENOVIA INC
NASDAQ
Biotechnology
$72.51M$2.160.47%-$13.97M-4.15x0.35
NTRB
NUTRIBAND INC
NASDAQ
Biotechnology
$34.33M$4.39-3.94%-$5.74M-4.67x0.07
NBRV
NABRIVA THERAPEUTICS PLC
NASDAQ
Biotechnology
$120.72M$0.19-2.55%-$45.57M-2.10x0.47
MRUS
MERUS NV
NASDAQ
Biotechnology
$647.59M$14.87-7.52%-$73.87M-7.95x0.40
BLI
BERKELEY LIGHTS INC
NASDAQ
Biotechnology
$295.05M$4.35-10.68%-$67.96M-3.75x0.38
VCYT
VERACYTE INC
NASDAQ
Biotechnology
$1.21B$16.94-5.57%-$24.83M-25.28x0.08
XENE
XENON PHARMACEUTICALS INC
NASDAQ
Biotechnology
$1.41B$26.49-6.79%-$82.03M-15.58x0.03
LEXX
LEXARIA BIOSCIENCE CORP
NASDAQ
Biotechnology
$11.19M$1.88-6.93%-$7.17M-1.40x0.02
SYBX
SYNLOGIC INC
NASDAQ
Biotechnology
$78.68M$1.12-7.44%-$56.46M-1.15x0.20
IMGN
IMMUNOGEN INC
NASDAQ
Biotechnology
$780.70M$3.54-0.84%-$127.44M-5.90x0.57
FNCH
FINCH THERAPEUTICS GROUP INC
NASDAQ
Biotechnology
$96.54M$2.03-10.96%-$65.49M-1.39x0.14
PTGX
PROTAGONIST THERAPEUTICS INC
NASDAQ
Biotechnology
$374.65M$7.70-1.66%-$119.50M-2.97x0.15
VRNA
VERONA PHARMA PLC
NASDAQ
Biotechnology
$252.34M$4.180.97%-$58.15M-4.02x0.34
LMNL
LIMINAL BIOSCIENCES INC
NASDAQ
Biotechnology
$15.83M$0.51-1.92%$24.83M0.86x1.65
ABCL
ABCELLERA BIOLOGICS INC
NASDAQ
Biotechnology
$2.07B$7.26-5.35%$311.96M10.08x0.32
JANX
JANUX THERAPEUTICS INC
NASDAQ
Biotechnology
$455.84M$10.95-1.44%-$43.61M-7.35x0.04
SGEN
SEAGEN INC
NASDAQ
Biotechnology
$24.57B$133.47-4.21%-$609.49M-35.40x0.21
VCNX
VACCINEX INC
NASDAQ
Biotechnology
$49.49M$1.162.65%-$19.77M-1.78x0.12
OCUL
OCULAR THERAPEUTIX INC
NASDAQ
Biotechnology
$237.95M$3.10-5.49%-$13.21M-10.69x1.35
DVAX
DYNAVAX TECHNOLOGIES CORP
NASDAQ
Biotechnology
$1.42B$11.28-1.14%$124.61M12.82x2.51
MRVI
MARAVAI LIFESCIENCES HOLDINGS INC
NASDAQ
Biotechnology
$8.71B$34.11-4.43%$353.50M18.54x3.63
RYTM
RHYTHM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$169.32M$3.36-1.47%-$186.83M-1.02x0.21
ITOS
ITEOS THERAPEUTICS INC
NASDAQ
Biotechnology
$588.91M$16.57-5.37%$390.19M1.96x0.36
BLCM
BELLICUM PHARMACEUTICALS INC
NASDAQ
Biotechnology
$12.23M$1.425.19%-$5.94M-71.00x0.46
HCM
HUTCHMED (CHINA) LTD
NASDAQ
Biotechnology
$1.49B$8.59-10.61%-$182.14M-6.87x0.34
RPRX
ROYALTY PHARMA PLC
NASDAQ
Biotechnology
$24.13B$39.74-0.77%$778.16M27.60x0.71
DYAI
DYADIC INTERNATIONAL INC
NASDAQ
Biotechnology
$66.42M$2.357.31%-$12.27M-5.34x0.13
ITCI
INTRA-CELLULAR THERAPIES INC
NASDAQ
Biotechnology
$5.37B$56.96-2.48%-$302.92M-15.65x0.10
FSTX
F-STAR THERAPEUTICS INC
NASDAQ
Biotechnology
$55.24M$2.57-6.20%-$32.71M-1.67x0.30
SRPT
SAREPTA THERAPEUTICS INC
NASDAQ
Biotechnology
$6.02B$68.84-3.87%-$303.14M-16.20x2.57
ADMA
ADMA BIOLOGICS INC
NASDAQ
Biotechnology
$361.29M$1.84-11.11%-$59.17M-3.83x1.43
JNCE
JOUNCE THERAPEUTICS INC
NASDAQ
Biotechnology
$224.78M$4.35-6.45%-$99.06M-2.20x0.14
ROIV
ROIVANT SCIENCES LTD
NASDAQ
Biotechnology
$2.71B$3.917.12%-$555.63M195.50x0.28
NHWK
NIGHTHAWK BIOSCIENCES INC
NYSEMKT
Biotechnology
$61.56M$2.403.90%-$35.01M-1.69x0.09

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in May 2022?

According to Zen Score, the 3 best biotechnology stocks to buy right now are:

1. COLLPLANT BIOTECHNOLOGIES (NASDAQ:CLGN)


COLLPLANT BIOTECHNOLOGIES (NASDAQ:CLGN) is the top biotech stock with a Zen Score of 79, which is 49 points higher than the biotech industry average of 30. It passed 25 out of 33 due diligence checks and has strong fundamentals. COLLPLANT BIOTECHNOLOGIES has seen its stock lose -40.33% over the past year, overperforming other biotech stocks by 4 percentage points.

COLLPLANT BIOTECHNOLOGIES has an average 1 year price target of $21.50, an upside of 138.62% from COLLPLANT BIOTECHNOLOGIES's current stock price of $9.01.

COLLPLANT BIOTECHNOLOGIES stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering COLLPLANT BIOTECHNOLOGIES, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. CATALYST PHARMACEUTICALS (NASDAQ:CPRX)


CATALYST PHARMACEUTICALS (NASDAQ:CPRX) is the second best biotech stock with a Zen Score of 74, which is 44 points higher than the biotech industry average of 30. It passed 24 out of 33 due diligence checks and has strong fundamentals. CATALYST PHARMACEUTICALS has seen its stock return 20.74% over the past year, overperforming other biotech stocks by 65 percentage points.

CATALYST PHARMACEUTICALS has an average 1 year price target of $11.60, an upside of 68.85% from CATALYST PHARMACEUTICALS's current stock price of $6.87.

CATALYST PHARMACEUTICALS stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering CATALYST PHARMACEUTICALS, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. EXELIXIS (NASDAQ:EXEL)


EXELIXIS (NASDAQ:EXEL) is the third best biotech stock with a Zen Score of 72, which is 42 points higher than the biotech industry average of 30. It passed 23 out of 33 due diligence checks and has strong fundamentals. EXELIXIS has seen its stock lose -25.25% over the past year, overperforming other biotech stocks by 19 percentage points.

EXELIXIS has an average 1 year price target of $32.67, an upside of 84.56% from EXELIXIS's current stock price of $17.70.

EXELIXIS stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 6 analysts covering EXELIXIS, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 4 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. SIGA TECHNOLOGIES (NASDAQ:SIGA)


SIGA TECHNOLOGIES (NASDAQ:SIGA) has an annual dividend yield of 4.92%, which is 3 percentage points higher than the biotech industry average of 1.71%.

SIGA TECHNOLOGIES's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. ROYALTY PHARMA (NASDAQ:RPRX)


ROYALTY PHARMA (NASDAQ:RPRX) has an annual dividend yield of 1.81%, which is the same as the biotech industry average of 1.71%.

ROYALTY PHARMA's dividend payout ratio of 48.6% indicates that its dividend yield is sustainable for the long-term.

3. NOVO NORDISK A S (NYSE:NVO)


NOVO NORDISK A S (NYSE:NVO) has an annual dividend yield of 1.48%, which is the same as the biotech industry average of 1.71%. NOVO NORDISK A S's dividend payout is not stable, having dropped more than 10% seven times in the last 10 years. NOVO NORDISK A S's dividend has shown consistent growth over the last 10 years.

NOVO NORDISK A S's dividend payout ratio of 52.5% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -2.9% in the last day, and down -4.26% over the last week. GENOCEA BIOSCIENCES was the among the top losers in the biotechnology industry, dropping -72.65% yesterday.

Genocea Biosciences shares are trading lower after the company announced it's winding down operations and delisting from NASDAQ.

What are the most undervalued biotech stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued biotech stocks right now are:

1. SESEN BIO (NASDAQ:SESN)


SESEN BIO (NASDAQ:SESN) is the most undervalued biotech stock based on WallStreetZen's Valuation Score. SESEN BIO has a valuation score of 100, which is 66 points higher than the biotech industry average of 34. It passed 7 out of 7 valuation due diligence checks.

SESEN BIO's stock has dropped -82.28% in the past year. It has underperformed other stocks in the biotech industry by -38 percentage points.

2. UNIVERSE PHARMACEUTICALS (NASDAQ:UPC)


UNIVERSE PHARMACEUTICALS (NASDAQ:UPC) is the second most undervalued biotech stock based on WallStreetZen's Valuation Score. UNIVERSE PHARMACEUTICALS has a valuation score of 100, which is 66 points higher than the biotech industry average of 34. It passed 7 out of 7 valuation due diligence checks.

UNIVERSE PHARMACEUTICALS's stock has dropped -67.6% in the past year. It has underperformed other stocks in the biotech industry by -23 percentage points.

3. COLLPLANT BIOTECHNOLOGIES (NASDAQ:CLGN)


COLLPLANT BIOTECHNOLOGIES (NASDAQ:CLGN) is the third most undervalued biotech stock based on WallStreetZen's Valuation Score. COLLPLANT BIOTECHNOLOGIES has a valuation score of 86, which is 52 points higher than the biotech industry average of 34. It passed 6 out of 7 valuation due diligence checks.

COLLPLANT BIOTECHNOLOGIES's stock has dropped -40.33% in the past year. It has overperformed other stocks in the biotech industry by 4 percentage points.

Are biotech stocks a good buy now?

51.7% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 154.79% over the next year.

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 0.22x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.